Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30

$8.18−0.26 (-3.08%)

Close on Nov 13, 2026Market cap $740.81MP/E –Yield –

Verastem operating margin

Operating margin is operating income as a percentage of revenue.

Verastem's operating margin for the twelve months ending Sep 30, 2026 was -193.7%. For fiscal 2025 it was -550.3%, against -1149.6% the year before. The highest annual figure on record is -55.8% in fiscal 2020.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-550.3%	+599.2
FY2024	Dec 31, 2024	-1149.6%	+1660.0
FY2022	Dec 31, 2022	-2809.6%	+181.6
FY2021	Dec 31, 2021	-2991.2%	−2935.4
FY2020	Dec 31, 2020	-55.8%	+702.4
FY2019	Dec 31, 2019	-758.1%	−403.4
FY2018	Dec 31, 2018	-354.8%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-313.3%	+48.9
Q2 FY2026	Jun 30, 2026	-81.6%	+1966.3
Q1 FY2026	Mar 31, 2026	-240.5%	+222.9
Q4 FY2025	Dec 31, 2025	-236.5%	+417.6
Q3 FY2025	Sep 30, 2025	-362.2%	+2667.4
Q2 FY2025	Jun 30, 2025	-2047.9%	+740252.1
Q1 FY2024	Jun 30, 2024	-463.4%	+2725.4
Q1 FY2022	Mar 31, 2022	-654.1%	+748.3
Q4 FY2021	Dec 31, 2021	-3029.5%	+281.5
Q3 FY2021	Sep 30, 2021	-742300.0%	−742319.1
Q2 FY2021	Jun 30, 2021	-3188.8%	−2695.1
Q1 FY2021	Mar 31, 2021	-1402.4%	−881.0
Q4 FY2020	Dec 31, 2020	-3311.1%	−2390.7
Q3 FY2020	Sep 30, 2020	19.1%	+308.1
Q2 FY2020	Jun 30, 2020	-493.7%	+726.9
Q1 FY2020	Mar 31, 2020	-521.3%	+1553.5
Q4 FY2019	Dec 31, 2019	-920.4%	+1910.9
Q3 FY2019	Sep 30, 2019	-289.0%	−149.9
Q2 FY2019	Jun 30, 2019	-1220.6%	−1038.6
Q1 FY2019	Mar 31, 2019	-2074.8%	–
Q4 FY2018	Dec 31, 2018	-2831.3%	–
Q3 FY2018	Sep 30, 2018	-139.1%	–
Q2 FY2018	Jun 30, 2018	-181.9%	–